P. Masson

1.6k total citations
28 papers, 860 citations indexed

About

P. Masson is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, P. Masson has authored 28 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 12 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in P. Masson's work include Asthma and respiratory diseases (13 papers), Phosphodiesterase function and regulation (8 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). P. Masson is often cited by papers focused on Asthma and respiratory diseases (13 papers), Phosphodiesterase function and regulation (8 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). P. Masson collaborates with scholars based in Canada, United States and Sweden. P. Masson's co-authors include Thomas R. Jones, Joshua Rokach, Robert N. Young, Yves Girard, A. W. Ford‐Hutchinson, Éric Champion, G. Holme, H. Piechuta, G. Brunet and Richard Frenette and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Tetrahedron Letters.

In The Last Decade

P. Masson

28 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Masson Canada 17 446 260 214 160 145 28 860
Yasuko Ashida Japan 12 371 0.8× 329 1.3× 179 0.8× 138 0.9× 123 0.8× 26 880
C. S. McFarlane Canada 14 288 0.6× 199 0.8× 100 0.5× 135 0.8× 98 0.7× 20 619
Ying K. Yee United States 16 254 0.6× 275 1.1× 122 0.6× 95 0.6× 291 2.0× 24 885
H. Salari Canada 16 328 0.7× 240 0.9× 176 0.8× 63 0.4× 54 0.4× 46 798
Winston S. Marshall United States 10 213 0.5× 220 0.8× 65 0.3× 82 0.5× 113 0.8× 20 564
J. Augstein United Kingdom 8 308 0.7× 117 0.5× 122 0.6× 144 0.9× 124 0.9× 13 585
Edward J. Kusner United States 10 209 0.5× 120 0.5× 84 0.4× 68 0.4× 65 0.4× 15 402
Hisashi Kuriki Japan 12 153 0.3× 164 0.6× 56 0.3× 264 1.6× 318 2.2× 31 701
Stephen L. Underwood United Kingdom 12 292 0.7× 171 0.7× 222 1.0× 41 0.3× 20 0.1× 16 588
E. Schillinger Germany 18 133 0.3× 243 0.9× 54 0.3× 236 1.5× 163 1.1× 58 1.1k

Countries citing papers authored by P. Masson

Since Specialization
Citations

This map shows the geographic impact of P. Masson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Masson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Masson more than expected).

Fields of papers citing papers by P. Masson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Masson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Masson. The network helps show where P. Masson may publish in the future.

Co-authorship network of co-authors of P. Masson

This figure shows the co-authorship network connecting the top 25 collaborators of P. Masson. A scholar is included among the top collaborators of P. Masson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Masson. P. Masson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chauret, Nathalie, David Claveau, Stephen H. Day, et al.. (2009). Alkyl-bridged substituted 8-arylquinolines as highly potent PDE IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(17). 5266–5269. 2 indexed citations
2.
Deschênes, Denis, Daniel Dubé, Michel Gallant, et al.. (2006). Nitrogen-bridged substituted 8-arylquinolines as potent PDE IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(10). 2608–2612. 3 indexed citations
3.
Robichaud, Annette, Stephanie A. Tuck, Stacia Kargman, et al.. (2005). Gob-5 Is Not Essential for Mucus Overproduction in Preclinical Murine Models of Allergic Asthma. American Journal of Respiratory Cell and Molecular Biology. 33(3). 303–314. 43 indexed citations
4.
Côté, Bernard, Richard Frenette, Marc Blouin, et al.. (2003). Substituted aminopyridines as potent and selective phosphodiesterase-4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(4). 741–744. 7 indexed citations
5.
Ducharme, Yves, Richard W. Friesen, Marc Blouin, et al.. (2003). Substituted 2-Pyridinemethanol derivatives as potent and selective phosphodiesterase-4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(11). 1923–1926. 12 indexed citations
6.
Frenette, Richard, Marc Blouin, Christine Brideau, et al.. (2002). Substituted 4-(2,2-diphenylethyl)pyridine-N-oxides as phosphodiesterase-4 inhibitors: SAR study directed toward the improvement of pharmacokinetic parameters. Bioorganic & Medicinal Chemistry Letters. 12(20). 3009–3013. 20 indexed citations
7.
Guay, Daniel, Pierre Hamel, Marc Blouin, et al.. (2002). Discovery of L-791,943: A potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor. Bioorganic & Medicinal Chemistry Letters. 12(11). 1457–1461. 45 indexed citations
8.
Muise, Eric S., Ian C. Chute, David Claveau, et al.. (2002). Comparison of inhibition of ovalbumin-induced bronchoconstriction in guinea pigs and in vitro inhibition of tumor necrosis factor-α formation with phosphodiesterase 4 (PDE4) selective inhibitors. Biochemical Pharmacology. 63(8). 1527–1535. 23 indexed citations
9.
Macdonald, Dwight, Hélène Perrier, Susana Liu, et al.. (2000). Hunting the Emesis and Efficacy Targets of PDE4 Inhibitors:  Identification of the Photoaffinity Probe 8-(3-Azidophenyl)-6- [(4-iodo-1H-1-imidazolyl)methyl]quinoline (APIIMQ). Journal of Medicinal Chemistry. 43(21). 3820–3823. 24 indexed citations
10.
Masson, P., et al.. (1998). Evolution Stages of Ovda Regio from Structural History: First Results. Lunar and Planetary Science Conference. 1603. 1 indexed citations
11.
Yergey, James A., et al.. (1994). Respiratory Tract Eicosanoid Measurement Using Microdialysis Sampling and GC/MS Detection. Pulmonary Pharmacology. 7(1). 35–41. 8 indexed citations
12.
Foulon, D, Éric Champion, P. Masson, Ian W. Rodger, & Thomas R. Jones. (1993). NK 1 and NK 2 Receptors Mediate Tachykinin and Resiniferatoxin-induced Bronchospasm in Guinea Pigs. American Review of Respiratory Disease. 148(4_pt_1). 915–921. 21 indexed citations
13.
Jones, Thomas R., Robert Zamboni, Michel Belley, et al.. (1991). Pharmacology of the leukotriene antagonist verlukast: The (R)-enantiomer of MK-571. Canadian Journal of Physiology and Pharmacology. 69(12). 1847–1854. 17 indexed citations
14.
15.
Vagianos, C., Stig Steen, P. Masson, et al.. (1990). Reversal of lethal citrate intoxication by intravenous infusion of calcium. An experimental study in pigs.. PubMed. 156(10). 671–5. 2 indexed citations
16.
Jones, Thomas R., Robert Zamboni, Michel Belley, et al.. (1989). Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Canadian Journal of Physiology and Pharmacology. 67(1). 17–28. 232 indexed citations
17.
Jones, Thomas R., Robert N. Young, Éric Champion, et al.. (1986). L-649,923, Sodium (βS*, γR*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)-γ-hydroxy-β-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist. Canadian Journal of Physiology and Pharmacology. 64(8). 1068–1075. 51 indexed citations
18.
Jones, Thomas R. & P. Masson. (1985). Comparative study of the pulmonary effects of intravenous leukotrienes and other bronchoconstrictors in anaesthetized guinea pig. Prostaglandins. 29(5). 799–817. 19 indexed citations
19.
Hamel, R., P. Masson, A. W. Ford‐Hutchinson, et al.. (1982). Differing mechanisms for leukotriene D4-induced bronchoconstriction in guinea pigs following intravenous and aerosol administration. Prostaglandins. 24(3). 419–432. 63 indexed citations
20.
Masson, P., et al.. (1982). Biological activity of leukotriene sulfones on respiratory tissues. International Journal of Immunopharmacology. 4(4). 351–351. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuko Ashida Breakdown of academic impact, for papers by C. S. McFarlane Breakdown of academic impact, for papers by Ying K. Yee Breakdown of academic impact, for papers by H. Salari Breakdown of academic impact, for papers by Winston S. Marshall Breakdown of academic impact, for papers by J. Augstein Breakdown of academic impact, for papers by Edward J. Kusner Breakdown of academic impact, for papers by Hisashi Kuriki Breakdown of academic impact, for papers by Stephen L. Underwood Breakdown of academic impact, for papers by E. Schillinger
Rankless by CCL
2026